Dr. Perl Discusses Upcoming CAR T-Cell Therapies for ALL – OncLive – OncLive
Mobile Computing Today |
Dr. Perl Discusses Upcoming CAR T-Cell Therapies for ALL – OncLive
OncLive Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses upcoming chimeric antigen receptor (CAR) T-cell therapies for patients with acute lymphoblastic leukemia (ALL). There has been interest in patients who lose … CAR T Cell Therapy Products And Increasing Number Of Patients … |
